Regulators’ approval of the 40 mg/mL applies to people with relapsing forms of MS. A mg/mL designation refers to the concentration of a substance in a liquid. In this case, it is 40 milligrams per milliliter of liquid.
Like Copaxone, Glatopa is an immunomodulatory injectable drug. It is made up of four amino acids found in the myelin sheath that protects nerve cell fibers — L-glutamic acid, L-alanine, L-tyrosine, and L-lysine. Glatopa reduces the frequency of MS relapses, studies have shown.
MS is an autoimmune disease, or one in which the body’s immune system attacks health tissue instead of invaders.
Scientists have yet to obtain a full understanding of how Glatopa works. But they believe it increases the number of the body’s regulatory T-cells, which in turns reduces the levels of the T-cells responsible for damaging the myelin sheath.
Scientists also believe that Glatopa boosts the activity of neurotrophic factors — molecules that help grow and maintain nerve cells.
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?